Blodgett Wealth Advisors LLC lessened its position in Eli Lilly and Company (NYSE:LLY – Free Report) by 7.3% during the 2nd quarter, HoldingsChannel.com reports. The fund owned 3,584 shares of the company’s stock after selling 283 shares during the period. Eli Lilly and Company accounts for about 1.7% of Blodgett Wealth Advisors LLC’s investment portfolio, […]
Blodgett Wealth Advisors LLC lessened its stake in shares of Advanced Micro Devices, Inc. (NASDAQ:AMD – Free Report) by 28.2% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 4,360 shares of the semiconductor manufacturer’s stock after selling 1,715 shares during the quarter. Blodgett […]
Cyndeo Wealth Partners LLC increased its position in shares of Honeywell International Inc. (NASDAQ:HON – Free Report) by 6.3% during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 36,370 shares of the conglomerate’s stock after buying an additional 2,152 shares during the period. Cyndeo Wealth […]
Carisma Therapeutics (NASDAQ:CARM – Get Free Report) had its price target boosted by equities research analysts at HC Wainwright from $10.00 to $11.00 in a note issued to investors on Friday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. HC Wainwright’s price objective points to a potential upside of 74.33% from […]
Blodgett Wealth Advisors LLC decreased its stake in JPMorgan Chase & Co. (NYSE:JPM) by 1.1% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 13,778 shares of the financial services provider’s stock after selling 148 shares during the quarter. JPMorgan Chase […]